PROFUSA, INC. Fair Value Adjustment of Warrants
PROFUSA, INC. (PFSA) reported Fair Value Adjustment of Warrants of -$418.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-19
- PROFUSA, INC. fair value adjustment of warrants for the quarter ending 2026-06-30 was -$418.00K, a 107.06% decline year-over-year.
- PROFUSA, INC. fair value adjustment of warrants for the quarter ending 2026-03-31 was -$258.00K, a 174.12% decline year-over-year.
- PROFUSA, INC. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$11.00K, a 125.28% decline year-over-year.
- PROFUSA, INC. fair value adjustment of warrants for the quarter ending 2025-09-30 was -$884.00K.
- PROFUSA, INC. fair value adjustment of warrants for fiscal 2024 was $539.53K.
- PROFUSA, INC. fair value adjustment of warrants for fiscal 2023 was -$701.15K.
- PROFUSA, INC. fair value adjustment of warrants for fiscal 2022 was -$6.36M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 8 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$418.00K 10-Q · filed 2026-08-19 | -$676.00K 10-Q · filed 2026-08-19 | -$687.00K derived: sum of 3 quarters · filed 2026-08-19 | -$1.57M derived: sum of 4 quarters · filed 2026-08-19 | |
| 2026-03-31 | -$258.00K 10-Q · filed 2026-05-15 | -$269.00K derived: sum of 2 quarters · filed 2026-05-15 | -$1.15M derived: sum of 3 quarters · filed 2026-05-15 | $4.76M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2025-12-31 | -$11.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | -$895.00K derived: sum of 2 quarters · filed 2026-05-01 | $5.02M derived: sum of 3 quarters · filed 2026-05-01 | -$895.00K S-1/A · filed 2026-05-01 | |
| 2025-09-30 | -$884.00K 10-Q · filed 2025-11-19 | $5.03M derived: sum of 2 quarters · filed 2025-11-19 | -$884.00K 10-Q · filed 2025-11-19 | $5.43M derived: sum of 4 quarters · filed 2025-11-19 | |
| 2025-06-30 | $5.92M 10-Q · filed 2025-08-14 | $6.27M 10-Q · filed 2025-08-14 | $6.31M derived: sum of 3 quarters · filed 2025-08-14 | $6.00M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2025-03-31 | $348.08K 10-Q · filed 2025-06-13 | $391.60K derived: sum of 2 quarters · filed 2025-06-13 | $87.02K derived: sum of 3 quarters · filed 2025-06-13 | $382.89K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-12-31 | $43.51K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$261.06K derived: sum of 2 quarters · filed 2025-03-31 | $34.81K derived: sum of 3 quarters · filed 2025-08-14 | $539.53K 10-K · filed 2025-03-31 | |
| 2024-09-30 | -$304.57K 10-Q · filed 2024-12-17 | -$8.70K derived: sum of 2 quarters · filed 2025-08-14 | $496.02K 10-Q · filed 2024-12-17 | -$15.05K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-06-30 | $295.87K 10-Q · filed 2025-08-14 | $800.60K 10-Q · filed 2025-08-14 | $289.53K derived: sum of 3 quarters · filed 2025-08-14 | $533.18K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $504.72K 10-Q · filed 2025-06-13 | -$6.35K derived: sum of 2 quarters · filed 2025-06-13 | $237.31K derived: sum of 3 quarters · filed 2025-06-13 | -$770.56K derived: sum of 4 quarters · filed 2025-06-13 | |
| 2023-12-31 | -$511.07K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$267.41K derived: sum of 2 quarters · filed 2025-03-31 | -$1.28M derived: sum of 3 quarters · filed 2025-03-31 | -$701.15K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $243.66K 10-Q · filed 2024-12-17 | -$764.22K derived: sum of 2 quarters · filed 2024-12-17 | -$190.08K 10-Q · filed 2024-12-17 | -$301.42K derived: sum of 4 quarters · filed 2024-12-17 | |
| 2023-06-30 | -$1.01M 10-Q · filed 2024-11-15 | -$433.74K 10-Q · filed 2024-11-15 | -$545.08K derived: sum of 3 quarters · filed 2024-11-15 | -$1.62M derived: sum of 4 quarters · filed 2024-11-15 | |
| 2023-03-31 | $574.14K 10-Q · filed 2024-10-09 | $462.80K derived: sum of 2 quarters · filed 2024-10-09 | -$611.58K derived: sum of 3 quarters · filed 2024-10-09 | -$1.91M derived: sum of 4 quarters · filed 2024-10-09 | |
| 2022-12-31 | -$111.34K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$1.19M derived: sum of 2 quarters · filed 2024-02-26 | -$2.48M derived: sum of 3 quarters · filed 2024-02-26 | -$6.36M 10-K · filed 2024-02-26 | |
| 2022-09-30 | -$1.07M 10-Q · filed 2023-11-20 | -$2.37M derived: sum of 2 quarters · filed 2023-11-20 | -$6.25M 10-Q · filed 2023-11-20 | ||
| 2022-06-30 | -$1.29M 10-Q · filed 2023-08-14 | -$5.17M 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | -$3.88M 10-Q · filed 2023-05-17 | ||||
| 2021-12-31 | -$597.57K 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |